Rystiggo needs marketing strategy to fully compete in myasthenia gravis space, says GlobalData
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Effective disaster response and management is a collaborative work
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
Vijaya Hospital, Chennai adopted Dozee’s AI-based contactless continuous remotemonitoring and early warning system to enhance patient safety
Subscribe To Our Newsletter & Stay Updated